Barif is a tablet from Square Pharmaceuticals Ltd., with the generic name Febuxostat. Only a doctor can determine whether this medicine is appropriate for a particular person.
There are 18 brands of Febuxostat listed in Bangladesh. 4 of them have a lower unit price than Barif. The lowest listed price is Fostat 80 mg Tablet at ৳ 10.00 per unit.
What is Barif 40 mg Tablet?
Made by Square Pharmaceuticals Ltd., Barif is a tablet whose active ingredient is Febuxostat. The tablet is available in an 40 mg strength. It is not recommended for treating asymptomatic hyperuricemia. The doctor decides the dose and course for each person.
Uses of Barif
Only a doctor can determine whether this medicine is appropriate for a particular person. Because it lowers uric acid gradually, it is part of ongoing care rather than a treatment for a sudden gout attack. Barif is used for the long-term management of high blood uric acid in people who have gout. Ask your doctor if you are unsure whether this medicine is right for your condition.
How to use Barif
It can be taken with or without food, and antacids do not affect it. Barif is taken by mouth. Swallow the tablet with water. Do not change the dose or stop early without asking your doctor. If you miss a dose or are unsure about timing, ask the doctor or pharmacist for guidance.
Side effects of Barif
Some people may notice side effects while taking Febuxostat. Some people may experience other effects. A higher rate of cardiovascular thromboembolic events was seen with Febuxostat than with allopurinol in clinical trials. Do not stop or change the medicine on your own. Tell your doctor if any side effect bothers you or does not go away.
Safety and precautions
Gout flares may occur when starting treatment; your doctor may prescribe additional medicine to manage this. Before taking Barif 40 mg tablet, tell your doctor if you are pregnant, planning to become pregnant, or breastfeeding. It belongs to pregnancy category C; use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Ask your doctor first if you are pregnant, breastfeeding, or have heart, liver or kidney problems.
Frequently asked questions
Why is Barif prescribed?
Only a doctor can determine whether this medicine is appropriate for a particular person. Because it lowers uric acid gradually, it is part of ongoing care rather than a treatment for a sudden gout attack.
How is Barif used?
It can be taken with or without food, and antacids do not affect it. Barif is taken by mouth.
What are the side effects of Barif?
Some people may notice side effects while taking Febuxostat. Some people may experience other effects.
Febuxostat is indicated for the chronic management of hyperuricemia in patients with gout. Febuxostat is not recommended for the treatment of asymptomatic hyperuricemia.
Pharmacology
Febuxostat is a non-purine, selective xanthine oxidase (XO) inhibitor. It decreases serum uric acid level by inhibiting xanthine oxidase, which is responsible for uric acid production. Xanthine oxidase breaks down hypoxanthine to xanthine and thus to uric acid. Febuxostat is not expected to inhibit other enzymes involved in purine and pyrimidine synthesis and metabolism at therapeutic concentrations.
Dosage & Administration
Febuxostat is recommended at 40 mg or 80 mg once daily. The recommended starting dose of Febuxostat is 40 mg once daily. For patients who do not achieve a serum uric acid less than 6 mg /dL after 2 weeks with 40 mg, Febuxostat 80 mg is recommended. Febuxostat can be administered without regard to food or antacid use. No dose adjustment is necessary when administering Febuxostat to patients with mild to moderate renal or hepatic impairment.
Interaction
Concomitant administration of Febuxostat with azathioprine, mercaptopurine or theophylline could increase plasma concentrations of these drugs resulting in severe toxicity.
Contraindications
Febuxostat is contraindicated in patients being treated with azathioprine, mercaptopurine, or theophylline.
Side Effects
The most common adverse events associated with the use of Febuxostat may include liver function abnormalities, nausea, arthralgia, and rash.
Pregnancy & Lactation
Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women. Febuxostat should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. It is not known whether this drug is excreted in human milk. Caution should be exercised when Febuxostat is administered to a nursing woman.
Precautions & Warnings
Gout Flare: An increase in gout flares is frequently observed during initiation of anti-hyperuricemic agents, including Febuxostat. If a gout flare occurs during treatment, Febuxostat need not be discontinued. Prophylactic therapy (i.e., non-steroidal anti-inflammatory drug (NSAID) or colchicine upon initiation of treatment) may be beneficial for up to six months.
Cardiovascular Events: A higher rate of cardiovascular thromboembolic events was observed in patients treated with febuxostat than allopurinol in clinical trials. Monitor for signs and symptoms of MI and stroke.
Liver Enzyme Elevation: Transaminase elevations have been observed in febuxostat -treated patients. Monitor liver function tests periodically.
Overdose Effects
Febustat was studied in healthy subjects in doses up to 300 mg daily for seven days without evidence of dose-limiting toxicities.
Storage Conditions
Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.
Alternative brands of Febuxostat
Other brands with the same generic name, cheapest first.